BIOLYPH is excited to exhibit at ADLM 2024 in Chicago
Minneapolis, MN, USA – July 9, 2024 – BIOLYPH, the leading Lyophilization Service Provider for the IVD, RUO, and Life Science industries, is excited to exhibit at ADLM 2024 in Chicago for the twenty-ninth time.
BIOLYPH transforms unstable liquid reagents into precise, room-temperature stable lyophilized aliquots, called LyoSpheres™, and packages them inside virtually any device. For over 31 years, countless IVD assay developers and Life Science manufacturers have trusted BIOLYPH’s Efficient, Effective, and Economical Lyophilization Services.
As the only dedicated, pure-play provider of lyophilization services in the world, BIOLYPH provides a seamless process from Proof-of-Concept through Production. Our state of the art production facilities allow BIOLYPH to flexibly scale to meet the needs of our clients at any volume, from small Proof-of-Concept batches to full-scale multi-million reaction runs. Optimized working sample LyoSpheres™ are provided for our clients’ evaluation in less than three weeks.
By applying our four synergistic areas of competency – Formulation Analysis, Excipient Formulation, Lyophilization, and Packaging – BIOLYPH compresses our clients’ development timelines, maximizes the quality, consistency, and value of their products, and helps them delight their customers.
During ADLM, BIOLYPH will have team members available in booth #3624 to discuss applications, answer questions, and lay out the straightforward process to achieve functional, stable lyophilized assays, reagents, and controls.